This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kirkpatrick, W. R.
Right arrow Articles by Patterson, T. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kirkpatrick, W. R.
Right arrow Articles by Patterson, T. F.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, October 2000, p. 2865-2868, Vol. 44, No. 10
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Efficacy of Voriconazole in a Guinea Pig Model of Disseminated Invasive Aspergillosis

William R. Kirkpatrick,1,* Robert K. McAtee,1 Annette W. Fothergill,2 Michael G. Rinaldi,2,3 and Thomas F. Patterson1,3

Departments of Medicine1 and Pathology,2 The University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229-3900, and Audie Murphy Division, South Texas Veterans Health Care System, San Antonio, Texas 782843

Received 21 December 1999/Returned for modification 29 April 2000/Accepted 10 July 2000

Voriconazole (VRC) was evaluated in an immunosuppressed-guinea pig model of invasive aspergillosis. VRC was more effective than amphotericin B or similar doses of itraconazole in the clearance of Aspergillus from tissues. VRC treatment regimens improved survival and significantly reduced tissue colony counts compared with those of controls.


* Corresponding author. Mailing address: The University of Texas Health Science Center at San Antonio, Department of Medicine, Division of Infectious Diseases, Mail Code 7881, 7703 Floyd Curl Dr., San Antonio, TX 78229-3900. Phone: (210) 567-4823. Fax: (210) 567-3303. E-mail: KIRKPATRICK{at}UTHSCSA.EDU.


Antimicrobial Agents and Chemotherapy, October 2000, p. 2865-2868, Vol. 44, No. 10
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Gencer, S., Ozer, S., Demirhan, G., Ak, O., Batirel, A. (2008). Angio-oedema as an unusual tolerable side effect of voriconazole therapy. J Med Microbiol 57: 1028-1031 [Abstract] [Full Text]  
  • Vallor, A. C., Kirkpatrick, W. R., Najvar, L. K., Bocanegra, R., Kinney, M. C., Fothergill, A. W., Herrera, M. L., Wickes, B. L., Graybill, J. R., Patterson, T. F. (2008). Assessment of Aspergillus fumigatus Burden in Pulmonary Tissue of Guinea Pigs by Quantitative PCR, Galactomannan Enzyme Immunoassay, and Quantitative Culture. Antimicrob. Agents Chemother. 52: 2593-2598 [Abstract] [Full Text]  
  • Meletiadis, J., Antachopoulos, C., Stergiopoulou, T., Pournaras, S., Roilides, E., Walsh, T. J. (2007). Differential Fungicidal Activities of Amphotericin B and Voriconazole against Aspergillus Species Determined by Microbroth Methodology. Antimicrob. Agents Chemother. 51: 3329-3337 [Abstract] [Full Text]  
  • Kirkpatrick, W. R., Najvar, L. K., Bocanegra, R., Patterson, T. F., Graybill, J. R. (2007). New Guinea Pig Model of Cryptococcal Meningitis. Antimicrob. Agents Chemother. 51: 3011-3013 [Abstract] [Full Text]  
  • Kirkpatrick, W. R., Coco, B. J., Patterson, T. F. (2006). Sequential or combination antifungal therapy with voriconazole and liposomal amphotericin B in a Guinea pig model of invasive aspergillosis.. Antimicrob. Agents Chemother. 50: 1567-1569 [Abstract] [Full Text]  
  • Clemons, K. V., Espiritu, M., Parmar, R., Stevens, D. A. (2005). Comparative Efficacies of Conventional Amphotericin B, Liposomal Amphotericin B (AmBisome), Caspofungin, Micafungin, and Voriconazole Alone and in Combination against Experimental Murine Central Nervous System Aspergillosis. Antimicrob. Agents Chemother. 49: 4867-4875 [Abstract] [Full Text]  
  • Krishnan, S., Manavathu, E. K., Chandrasekar, P. H. (2005). A comparative study of fungicidal activities of voriconazole and amphotericin B against hyphae of Aspergillus fumigatus. J Antimicrob Chemother 55: 914-920 [Abstract] [Full Text]  
  • Stephens-Romero, S. D., Mednick, A. J., Feldmesser, M. (2005). The Pathogenesis of Fatal Outcome in Murine Pulmonary Aspergillosis Depends on the Neutrophil Depletion Strategy. Infect. Immun. 73: 114-125 [Abstract] [Full Text]  
  • Pfaller, M. A., Sheehan, D. J., Rex, J. H. (2004). Determination of Fungicidal Activities against Yeasts and Molds: Lessons Learned from Bactericidal Testing and the Need for Standardization. Clin. Microbiol. Rev. 17: 268-280 [Abstract] [Full Text]  
  • Najvar, L. K., Cacciapuoti, A., Hernandez, S., Halpern, J., Bocanegra, R., Gurnani, M., Menzel, F., Loebenberg, D., Graybill, J. R. (2004). Activity of Posaconazole Combined with Amphotericin B against Aspergillus flavus Infection in Mice: Comparative Studies in Two Laboratories. Antimicrob. Agents Chemother. 48: 758-764 [Abstract] [Full Text]  
  • Graybill, J. R., Bocanegra, R., Najvar, L. K., Hernandez, S., Larsen, R. A. (2003). Addition of Caspofungin to Fluconazole Does Not Improve Outcome in Murine Candidiasis. Antimicrob. Agents Chemother. 47: 2373-2375 [Abstract] [Full Text]  
  • Van Epps, H. L., Feldmesser, M., Pamer, E. G. (2003). Voriconazole Inhibits Fungal Growth without Impairing Antigen Presentation or T-Cell Activation. Antimicrob. Agents Chemother. 47: 1818-1823 [Abstract] [Full Text]  
  • Pearson, M. M, Rogers, P D., Cleary, J. D, Chapman, S. W (2003). Voriconazole: A New Triazole Antifungal Agent. The Annals of Pharmacotherapy 37: 420-432 [Abstract] [Full Text]  
  • MacCallum, D. M., Odds, F. C. (2002). Influence of grapefruit juice on itraconazole plasma levels in mice and guinea pigs. J Antimicrob Chemother 50: 219-224 [Abstract] [Full Text]  
  • Kirkpatrick, W. R., Perea, S., Coco, B. J., Patterson, T. F. (2002). Efficacy of Caspofungin Alone and in Combination with Voriconazole in a Guinea Pig Model of Invasive Aspergillosis. Antimicrob. Agents Chemother. 46: 2564-2568 [Abstract] [Full Text]  
  • Kirkpatrick, W. R., Perea, S., Coco, B. J., Patterson, T. F. (2002). Efficacy of ravuconazole (BMS-207147) in a guinea pig model of disseminated aspergillosis. J Antimicrob Chemother 49: 353-357 [Abstract] [Full Text]